Osphos is the one FDA accepted intramuscular bisphosphonate injection for the Charge of the clinical indications associated with navicular syndrome in horses. This incredibly early reaction will not be an indication of the prolonged-expression effectiveness from the medication (it might be impartial of the principle, bone modifying outcomes). In